In this work, we propose a novel technique for in-vivo proton therapy range verification. This technique makes use of a small hadron tumour marker, 92Mo, implanted at a short known distance from the clinical treatment volume. Signals emitted from the marker during treatment can provide a direct measurement of the proton beam energy at the marker's position. Fusion-evaporation reactions between the proton beam and marker nucleus result in the emission of delayed characteristic γ rays, which are detected off-beam for an improved signal-to-noise ratio. In order to determine the viability of this technique and to establish an experimental setup for future work, the Monte Carlo package GEANT4 was used in combination with ROOT to simulate a treatment scenario with the new method outlined in this work. These simulations show that analyzing the intensity of delayed γ rays produced from competing reactions yields a precise measurement of the range of the proton beam relative to the marker, with sub-millimeter uncertainty.
@article{arxiv.2002.00543,
title = {GEANT4 simulation of a new range verification method using delayed gamma spectroscopy of a Mo-92 marker},
author = {Eva Kasanda and Christine Burbadge and Vinzenz Bildstein and Josef Turko and Artemis Spyrou and Cornelia Höhr and Dennis Mücher},
journal= {arXiv preprint arXiv:2002.00543},
year = {2020}
}